In this episode, we’re joined by Dr. Keith Berkle, chair of the Privia Medical Group — Mid-Atlantic Board of Governors and president of Virginia Women’s Center, who discusses the challenges OBGYNs face in transitioning to value-based care.
Through a new partnership, Tia Health’s primary care providers can now refer women in need of mental health support to Talkspace, where they can access therapy and psychiatric services.
Neurologists and health care practitioners must evolve with the world. Telemedicine carts assist in this evolution by serving as an intermediary between patients and doctors.
Why has there been so little progress against the rate of osteoporotic fractures and the associated morbidity and mortality? The deaths are real, the pain and suffering are real — and almost all of us have witnessed it. And, of course, the cost to our health system, $57 billion per year, is real.
A new report from ProgenyHealth highlights the importance of taking a multipronged approach to identifying and managing risk factors for maternal health and taking steps to reduce the risks of premature births.
Tia Health recently launched its longevity service line, which is starting with a focus on heart health. It includes labs and one-on-one provider guidance.
Organon said OG-6219 did not beat a placebo in a mid-stage clinical trial whose main goal was to measure the change in pelvic pain caused by endometriosis. The twice-daily pill came from Organon’s 2021 acquisition of Forendo Pharma.
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
In this episode, we’re joined by Julia Lasater, management consulting senior analyst at Accenture, and Amani Bright, senior program manager at Springboard Enterprises. They discuss the key takeaways of their recent women's health report.
Monarch, which launched Tuesday, provides the support and technology to help women's health providers create their own independent practices.
Heranova Lifesciences recently launched a noninvasive blood test to diagnose endometriosis. The standard diagnostic method is laparoscopy, which requires anesthesia, followed by histological confirmation. With its blood test, Heranova seeks to replace the diagnostic function of laparoscopy, thus reserving surgical intervention only for therapeutic purposes.
In this episode, we’re joined by Margaret Malone, principal of Flare Capital Partners. She discusses the investment trends she’s following in the women’s health space and advice she has for startups.
Explore top-tier aesthetic certification programs that blend theory with hands-on training — perfect for health care pros ready to elevate their practice
The women’s health market offers enormous potential for investment and innovation. While challenges related to systemic inequalities remain, progress in venture capital funding is encouraging. Likewise, the overall increase in patent filings related to breast cancer, endometriosis, and other conditions appears to reflect a growing interest in women’s health.
Women's Health Access Matters recently launched the Innovator's Circle, which brings together leaders from women’s health-focused funds, including Amboy Street Ventures, Emmeline Ventures and March of Dimes.
Healthcare and benefits leaders must step up to provide menopausal women with the full-spectrum care they need to protect musculoskeletal and metabolic health for lifelong strength and well-being.
Women most affected by both functional and serious GI conditions, especially in midlife, are often dismissed, misdiagnosed, or forced to endure prolonged waits for specialist care.
Teal Health received FDA approval for the first-ever at-home cervical cancer test, which seeks to give patients an alternative to the in-office pap smear. The test is already covered by four major payers in California.